1.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: Sor451107ctil, NCT00463463
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: SHEBA-07-4466-AN-CTIL, NCT00491491
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-MC998C, NCI-312, NCT00012298
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: ID01-233, NCT00048737
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 51 to 75
Sponsor: Other
Protocol IDs: KRDI-TUM-R-F-015-V-0030-I, EU-20633, NCT00397800
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 6th radioimmunotherapy prot., EudraCT number: 2007-002762-35, NCT00761384
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZEV0701, NCT00807196
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BIDMC-2003P-000182, NCT00073957
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: BIDMC-2004P-000044, NCT00110149
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Ritux plus TNI, NCT00147953
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: No age limit
Sponsor: Other
Protocol IDs: ID03-0287, NCT00290511
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EUDRACT 2005-000699-41, NCT00354822
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TH011103, NCT00386321
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCCC-2005133, SCCC-20060249, SCCC-20060078, SCCC # 2005133, NCT00453102
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BMA-05-017-ZEV, NCT00438581
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: TH011101, NCT00440583
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0512, NCT00493467
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: CHNMC-05149, 05149, NCT00577278
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: USCTU-SCHRIFT-06-DOG05-44, USCTU-SCHRIFT, USCTU-RHM-CAN0542, SCHRIFT-06-DOG05-44/RHM-CAN0542, EUDRACT 2007-000222-51, EU-20819, NCT00637832
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 to 80
Sponsor: Other
Protocol IDs: CALACASS-3RCHOPZ, 3 R CHOP Z, INCA-RECF0624, EUDRACT-2006-006179-19, CALACASS-2006/27, NCT00690560
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: GELTAMO-Z-BEAM LDGGB, EudraCT No.: 2007-003198 - 22, NCT00646750
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UARIZ-HSC-0567, 05-0303-01, HSC#0567, UARIZ-SRC17899, NCT00732498
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CHNMC-07076, 07076, NCT00695409
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZBEAM2, EUDRACT: 2007-000270-23, NCT00689169
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GOTEL-FL1LC-0701, Eudra-CT 2007-003091-19, NCT00722930
|
